| Dr Kevin Thang Pham I, DDS | |
|
7746 Lorraine Ave Ste 204, Stockton, CA 95210-4234 | |
| (209) 475-0869 | |
| (209) 475-0859 |
| Full Name | Dr Kevin Thang Pham I |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 7746 Lorraine Ave Ste 204, Stockton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003900705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 48979 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Thang Pham I, DDS 7746 Lorraine Ave Ste 204, Stockton, CA 95210-4234 Ph: (209) 475-0869 | Dr Kevin Thang Pham I, DDS 7746 Lorraine Ave Ste 204, Stockton, CA 95210-4234 Ph: (209) 475-0869 |
News Archive
Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA) has awarded Pfenex a contract providing for up to a total of $18.8 million in funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government. The contract will support the development of a robust Pfenex Expression Technology based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax.
It's difficult to conceptualize a world where humans could casually manipulate nanoscale objects at will or even control their own biological matter at a cellular level with light.
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
The Royal College of Surgeons in Ireland (RCSI) is leading an international team of scientists on a major research study which aims to predict colorectal cancer patients' response to the 'angiogenesis inhibitor' class of anti-cancer drug which prevents growth of tumour blood vessels. The study will facilitate a more focused therapeutic approach thus limiting side-effects in patients.
› Verified 4 days ago
Dr. Scott Ernest Adams, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1710 E March Ln, Ste 2b, Stockton, CA 95210 Phone: 209-474-1000 Fax: 209-474-8429 | |
Zarjan Khan, Dentist Medicare: Not Enrolled in Medicare Practice Location: 7860 West Ln Ste B, Stockton, CA 95210 Phone: 209-235-0295 | |
Dr. Roger K Lang, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 3031 W March Ln, Suite 318e, Stockton, CA 95219 Phone: 209-956-0601 Fax: 209-952-8845 | |
Thomas E Bianchi, DDS Dentist Medicare: Medicare Enrolled Practice Location: 3427 Deer Park Dr, Suite A, Stockton, CA 95219 Phone: 209-478-2252 | |
Dr. Phuong Le Du, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 8215 Powell Dr, Stockton, CA 95212 Phone: 209-351-5203 | |
Ebrahim Shafieha, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 902 E Hammer Lane, Stockton, CA 95210 Phone: 209-957-9500 Fax: 209-957-9508 |